- Knopp Neurosciences Completes Series B2 Financing, Raising Total Capitalization to $27 Million November 19, 2008
- Knopp Neurosciences Initiates Phase 2 Study of KNS-760704 in Amyotrophic Lateral Sclerosis April 7, 2008
- Knopp Neurosciences Completes First Series B Financing of $10 Million January 22, 2008
- Knopp Neurosciences Presents Results of Phase 1 Ascending Single-Dose Study of KNS-760704 December 3, 2007
- Knopp Neurosciences Receives Orphan Designation October 15, 2007
- Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy October 3, 2007
- Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 September 24, 2007
Thomas Petzinger Jr.